It has been reported in small case series and studies that intracoronary administration of tissue plasminogen activator (t-PA) reduces coronary thrombus and improves thrombolysis in myocardial infarction (TIMI) flow grade [7,8]. This evidence concerns the gene PLAT and myocardial infarction.